AMED.DE vs. LYMS.DE
AMED.DE (Amundi MSCI EMU ESG Leaders Select UCITS ETF DR EUR (C)) and LYMS.DE (Amundi Nasdaq-100 II UCITS ETF Acc) are both exchange-traded funds - AMED.DE is a Europe Equities fund tracking the MSCI EMU ESG Leaders Select 5% Issuer Capped, while LYMS.DE is a Nasdaq-100 fund tracking the Nasdaq 100®. Both are passively managed. Over the past 10 years, AMED.DE returned 9.75%/yr vs 21.41%/yr for LYMS.DE. A 0.57 correlation means they provide meaningful diversification when combined. AMED.DE charges 0.25%/yr vs 0.22%/yr for LYMS.DE.
Performance
AMED.DE vs. LYMS.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AMED.DE achieves a 16.87% return, which is significantly lower than LYMS.DE's 20.63% return. Over the past 10 years, AMED.DE has underperformed LYMS.DE with an annualized return of 9.75%, while LYMS.DE has yielded a comparatively higher 21.41% annualized return.
AMED.DE
- 1D
- 0.51%
- 1M
- 7.96%
- YTD
- 16.87%
- 6M
- 18.54%
- 1Y
- 26.45%
- 3Y*
- 16.11%
- 5Y*
- 10.41%
- 10Y*
- 9.75%
LYMS.DE
- 1D
- -0.86%
- 1M
- 9.25%
- YTD
- 20.63%
- 6M
- 19.42%
- 1Y
- 37.94%
- 3Y*
- 24.71%
- 5Y*
- 18.88%
- 10Y*
- 21.41%
AMED.DE vs. LYMS.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AMED.DE Amundi MSCI EMU ESG Leaders Select UCITS ETF DR EUR (C) | 16.87% | 20.15% | 5.95% | 16.68% | -10.71% | 20.90% | -1.35% | 27.22% | -12.98% | 11.86% |
LYMS.DE Amundi Nasdaq-100 II UCITS ETF Acc | 20.63% | 7.15% | 33.72% | 51.52% | -29.87% | 39.59% | 34.60% | 42.84% | 3.18% | 15.91% |
Correlation
The correlation between AMED.DE and LYMS.DE is 0.59, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.59 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.49 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.57 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.59 |
Correlation (All Time) Calculated using the full available price history since Feb 25, 2010 | 0.57 |
The correlation between AMED.DE and LYMS.DE shifts across timeframes, from 0.49 (3 years) to 0.59 (10 years), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AMED.DE vs. LYMS.DE — Risk / Return Rank
AMED.DE
LYMS.DE
AMED.DE vs. LYMS.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amundi MSCI EMU ESG Leaders Select UCITS ETF DR EUR (C) (AMED.DE) and Amundi Nasdaq-100 II UCITS ETF Acc (LYMS.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AMED.DE | LYMS.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.67 | ||
| Sortino ratioReturn per unit of downside risk | -0.61 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.42 | -0.09 |
| Calmar ratioReturn relative to maximum drawdown | 2.49 | 3.77 | -1.28 |
| Martin ratioReturn relative to average drawdown | 9.40 | 11.23 | -1.83 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| AMED.DE | LYMS.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.74 | 2.40 | -0.67 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.65 | 0.94 | -0.29 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.57 | 1.08 | -0.51 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.47 | 0.77 | -0.30 |
Drawdowns
AMED.DE vs. LYMS.DE - Drawdown Comparison
The maximum AMED.DE drawdown since its inception was -38.35%, smaller than the maximum LYMS.DE drawdown of -50.00%. Use the drawdown chart below to compare losses from any high point for AMED.DE and LYMS.DE.
Loading charts...
Drawdown Indicators
| AMED.DE | LYMS.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.35% | -50.00% | +11.65% |
Max Drawdown (1Y)Largest decline over 1 year | -10.56% | -10.02% | -0.54% |
Max Drawdown (3Y)Largest decline over 3 years | -14.07% | -26.74% | +12.67% |
Max Drawdown (5Y)Largest decline over 5 years | -24.06% | -31.12% | +7.06% |
Max Drawdown (10Y)Largest decline over 10 years | -38.35% | -31.12% | -7.23% |
Current DrawdownCurrent decline from peak | -0.17% | -0.86% | +0.69% |
Average DrawdownAverage peak-to-trough decline | -6.69% | -8.78% | +2.09% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.81% | 3.37% | -0.56% |
Volatility
AMED.DE vs. LYMS.DE - Volatility Comparison
Amundi MSCI EMU ESG Leaders Select UCITS ETF DR EUR (C) (AMED.DE) has a higher volatility of 5.61% compared to Amundi Nasdaq-100 II UCITS ETF Acc (LYMS.DE) at 4.37%. This indicates that AMED.DE's price experiences larger fluctuations and is considered to be riskier than LYMS.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AMED.DE | LYMS.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.61% | 4.37% | +1.24% |
Volatility (6M)Calculated over the trailing 6-month period | 12.64% | 10.99% | +1.65% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.19% | 15.73% | -0.54% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.87% | 19.91% | -4.04% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.00% | 19.68% | -2.68% |
AMED.DE vs. LYMS.DE - Expense Ratio Comparison
AMED.DE has a 0.25% expense ratio, which is higher than LYMS.DE's 0.22% expense ratio. However, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.
Dividends
AMED.DE vs. LYMS.DE - Dividend Comparison
Neither AMED.DE nor LYMS.DE has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMED.DE Amundi MSCI EMU ESG Leaders Select UCITS ETF DR EUR (C) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LYMS.DE Amundi Nasdaq-100 II UCITS ETF Acc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.65% | 0.69% | 0.76% | 1.09% | 1.18% |
Frequently Asked Questions
AMED.DE and LYMS.DE have a correlation of 0.59, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, LYMS.DE is cheaper at 0.22% per year. The better choice depends on whether you care most about return, fees, risk, or income.
LYMS.DE is cheaper with a 0.22% expense ratio, compared with 0.25% for AMED.DE.
AMED.DE is categorized as Europe Equities, while LYMS.DE is Nasdaq-100. AMED.DE tracks MSCI EMU ESG Leaders Select 5% Issuer Capped, while LYMS.DE tracks Nasdaq 100®. Their fees differ too: 0.25% for AMED.DE and 0.22% for LYMS.DE.
Find the right allocation for AMED.DE and LYMS.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer